The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Quinolone Antibiotics Induce Shiga Toxin–Encoding Bacteriophages, Toxin Production, and Death in Mice
Abstract
Shiga toxin-producing Escherichia coli (STEC) cause significant disease; treatment is supportive and antibiotic use is controversial. Ciprofloxacin but not fosfomycin causes Shiga toxin-encoding bacteriophage induction and enhanced Shiga toxin (Stx) production from E. coli O157:H7 in vitro. The potential clinical relevance of this was examined in mice colonized with E. coli O157:H7 and given either ciprofloxacin or fosfomycin. Both antibiotics caused a reduction in fecal STEC. However, animals treated with ciprofloxacin had a marked increase in free fecal Stx, associated with death in two-thirds of the mice, whereas fosfomycin did not. Experiments that used a kanamycin-marked Stx2 prophage demonstrated that ciprofloxacin, but not fosfomycin, caused enhanced intraintestinal transfer of Stx2 prophage from one E. coli to another. These observations suggest that treatment of human STEC infection with bacteriophage-inducing antibiotics, such as fluoroquinolones, may have significant adverse clinical consequences and that fluoroquinolone antibiotics may enhance the movement of virulence factors in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Donnenberg, M. S., & Kaper, J. B. (1991) · Infection and Immunity · doi:10.1128/iai.59.12.4310-4317.1991 · Cited by 1,061
O'Brien, A. D., Newland, J. W., Miller, S. F., Holmes, R. K., Smith, H. W., & Formal, S. B. (1984) · Science · doi:10.1126/science.6387911 · Cited by 617
INFECTIONS OF THE GASTRO-INTESTINAL TRACT
(1980) · An Introduction to Microbiology for Nurses · doi:10.1016/b978-0-433-30301-5.50017-5 · Cited by 617
A Severe Outbreak of Escherichia coli O157:H7–Associated Hemorrhagic Colitis in a Nursing Home
Carter, A. O., Borczyk, A. A., Carlson, J. A. K., Harvey, B., Hockin, J. C., Karmali, M. A., Krishnan, C., Korn, D. A., & Lior, H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712103172403 · Cited by 536
Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus
Calderwood, S. B., & Mekalanos, J. J. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.10.4759-4764.1987 · Cited by 334
The pathogenesis of Shigella Diarrhea
Keusch, G. T., Grady, G. F., Mata, L. J., & McIver, J. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106915 · Cited by 308
Self-citationPavia, A. T., Nichols, C. R., Green, D. P., Tauxe, R. V., Mottice, S., Greene, K. D., Wells, J. G., Siegler, R. L., Brewer, E. D., Hannon, D., et al. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81600-2 · Cited by 254
Escherichia coli O157 : H7 and other enterohemorrhagic Escherichia coli
Griffin, P. M. (1995) · Medical Entomology and Zoology · Cited by 239
Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7
Wadolkowski, E. A., Burris, J. A., & O'Brien, A. D. (1990) · Infection and Immunity · doi:10.1128/iai.58.8.2438-2445.1990 · Cited by 238
Neely, M. N., & Friedman, D. I. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00890.x · Cited by 232
Cited by
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583
Microbiological effects of sublethal levels of antibiotics
Andersson, D. I., & Hughes, D. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3270 · Cited by 1,757
Phages and the Evolution of Bacterial Pathogens: from Genomic Rearrangements to Lysogenic Conversion
Brüssow, H., Canchaya, C., & Hardt, W.-D. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.3.560-602.2004 · Cited by 1,725
Recent Advances in Understanding Enteric Pathogenic Escherichia coli
Croxen, M. A., Law, R. J., Scholz, R., Keeney, K. M., Wlodarska, M., & Finlay, B. B. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00022-13 · Cited by 1,569
Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease
Norman, J. M., Handley, S. A., Baldridge, M. T., Droit, L., Liu, C. Y., Keller, B. C., Kambal, A., Monaco, C. L., Zhao, G., Fleshner, P., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.002 · Cited by 1,285
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Practice Guidelines for the Management of Infectious Diarrhea
Guerrant, R. L., Van Gilder, T., Steiner, T. S., Thielman, N. M., Slutsker, L., Tauxe, R. V., Hennessy, T., Griffin, P. M., DuPont, H., Bradley Sack, R., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/318514 · Cited by 1,074
Origins of the E. coli Strain Causing an Outbreak of Hemolytic–Uremic Syndrome in Germany
Rasko, D. A., Webster, D. R., Sahl, J. W., Bashir, A., Boisen, N., Scheutz, F., Paxinos, E. E., Sebra, R., Chin, C.-S., Iliopoulos, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106920 · Cited by 823
Self-citationDifferent drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
Mechanisms and consequences of intestinal dysbiosis
Weiss, G. A., & Hennet, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2509-x · Cited by 775
Antibiotics as intermicrobial signaling agents instead of weapons
Linares, J. F., Gustafsson, I., Baquero, F., & Martinez, J. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608949103 · Cited by 658
The multifaceted roles of antibiotics and antibiotic resistance in nature
Sengupta, S., Chattopadhyay, M. K., & Grossart, H.-P. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00047 · Cited by 629
Importance of prophages to evolution and virulence of bacterial pathogens
Fortier, L.-C., & Sekulovic, O. (2013) · Virulence · doi:10.4161/viru.24498 · Cited by 577
Targeting QseC Signaling and Virulence for Antibiotic Development
Rasko, D. A., Moreira, C. G., Li, D. R., Reading, N. C., Ritchie, J. M., Waldor, M. K., Williams, N., Taussig, R., Wei, S., Roth, M., et al. (2008) · Science · doi:10.1126/science.1160354 · Cited by 519
Self-citationTauxe, R. V. (2002) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(02)00232-5 · Cited by 518
Martínez, J. L., & Baquero, F. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.647-679.2002 · Cited by 514
Bacteriophage Control of Bacterial Virulence
Wagner, P. L., & Waldor, M. K. (2002) · Infection and Immunity · doi:10.1128/iai.70.8.3985-3993.2002 · Cited by 500
Self-citationKaper, J. B. (2005) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.06.008 · Cited by 486
Microbial Persistence and the Road to Drug Resistance
Cohen, N. R., Lobritz, M. A., & Collins, J. J. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.009 · Cited by 460
Thielman, N. M., & Guerrant, R. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp031534 · Cited by 456
Bacteriophage-mediated spread of bacterial virulence genes
Penadés, J. R., Chen, J., Quiles-Puchalt, N., Carpena, N., & Novick, R. P. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.11.019 · Cited by 367
Maiques, E., Úbeda, C., Campoy, S., Salvador, N., Lasa, I., Novick, R. P., Barbé, J., & Penadés, J. R. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.7.2726-2729.2006 · Cited by 365
The bacterial LexA transcriptional repressor
Butala, M., Žgur-Bertok, D., & Busby, S. J. W. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8378-6 · Cited by 319
Úbeda, C., Maiques, E., Knecht, E., Lasa, Í., Novick, R. P., & Penadés, J. R. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04584.x · Cited by 311
Menne, J., Nitschke, M., Stingele, R., Abu-Tair, M., Beneke, J., Bramstedt, J., Bremer, J. P., Brunkhorst, R., Busch, V., Dengler, R., et al. (2012) · BMJ · doi:10.1136/bmj.e4565 · Cited by 309
Antimicrobial resistance of foodborne pathogens
White, D. G., Zhao, S., Simjee, S., Wagner, D. D., & McDermott, P. F. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01554-x · Cited by 291
The antibiotic resistance “mobilome”: searching for the link between environment and clinic
Perry, J. A., & Wright, G. D. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00138 · Cited by 287
A millennium update on pediatric diarrheal illness in the developing world.
O’Ryan, M., Prado, V., & Pickering, L. K. (2005) · Seminars in Pediatric Infectious Diseases · doi:10.1053/j.spid.2005.12.008 · Cited by 283
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
Joseph, A., Cointe, A., Mariani Kurkdjian, P., Rafat, C., & Hertig, A. (2020) · Toxins · doi:10.3390/toxins12020067 · Cited by 278
Wong, C. S., Mooney, J. C., Brandt, J. R., Staples, A. O., Jelacic, S., Boster, D. R., Watkins, S. L., & Tarr, P. I. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis299 · Cited by 274
Killing niche competitors by remote-control bacteriophage induction
Selva, L., Viana, D., Regev-Yochay, G., Trzcinski, K., Corpa, J. M., Lasa, Í., Novick, R. P., & Penadés, J. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809600106 · Cited by 172
Takahashi, M., Taguchi, H., Yamaguchi, H., Osaki, T., Komatsu, A., & Kamiya, S. (2004) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.03.010 · Cited by 159
Smith, K. E., Wilker, P. R., Reiter, P. L., Hedican, E. B., Bender, J. B., & Hedberg, C. W. (2012) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31823096a8 · Cited by 156
DuPont, H. L. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0904162 · Cited by 155
Guideline for the Antibiotic Use in Acute Gastroenteritis
Kim, Y. J., Park, K.-H., Park, D.-A., Park, J., Bang, B. W., Lee, S. S., Lee, E. J., Lee, H.-J., Hong, S. K., & Kim, Y. R. (2019) · Infection & Chemotherapy · doi:10.3947/ic.2019.51.2.217 · Cited by 46
“In studies employing animal models and in vitro models of STEC infection, fluoroquinolone and trimethoprim-sulfamethoxazole (TMP/SMX) antibiotics were associated with increased secretion of Shiga toxin, but fosfomycin, azithromycin, and rifaximin did not increase the excretion of Shiga toxin [71-73].”
BackgroundThe Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ
Bury, S., Soundararajan, M., Bharti, R., von Bünau, R., Förstner, K. U., & Oelschlaeger, T. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00929 · Cited by 21
Clinical Guideline for the Diagnosis and Treatment of Gastrointestinal Infections
The Korean Society of Infectious Diseases, Korean Society for Chemotherapy, & The Korean Society of Clinical Microbiology (2010) · Infection and Chemotherapy · doi:10.3947/ic.2010.42.6.323 · Cited by 18
Metadata
- Authors
- Zhang, X., McDaniel, A. D., Wolf, L. E., Keusch, G. T., Waldor, M. K., & Acheson, D. W. K.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-02
- Volume
- 181
- Issue
- 2
- Pages
- 664-670
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2137994690
- Cited by
- 603
- References
- 19
- FWCI
- 12.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.